The MAFLD group also had higher incidences of smoking, heavy drinking, and metabolic abnormalities such as hypertension, diabetes mellitus, hyperuricemia, and elevated liver enzymes (ALT, AST, ALP, GGT), as well as worse lipid profiles (higher triglycerides and lower HDL-C) (Table 1) (all p<0.001). The gene discussed is GPT; the disease is hyperuricemia.